FDA Class II · Drug · August 19, 2026
Diovan (valsartan) 160 mg recall — Novartis Pharmaceuticals Corporation
Failed Dissolution Specifications
Official ID D-0746-2026 · Official record ↗
Novartis Pharmaceuticals recalls
Recall found. Novartis Pharmaceuticals is named in FDA Class II recall D-0746-2026 covering Diovan (valsartan) 160 mg. Hazard: Failed Dissolution Specifications Identifying details: Lot AV5913C, Expiry: 6/2027. Status: Ongoing.
Models with recalls
All Novartis Pharmaceuticals recalls
Verify with the official sources:
- CPSC — consumer products ↗ (aggregated here)
- NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
- FDA — food, drugs, medical devices ↗ (aggregated here)
- USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
- Recalls.gov — the U.S. government’s all-agency portal ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked September 7, 2026 at 6:00 AM UTC.